TABLE 5.

Results of repeat and/or follow-up tympanocenteses among patients classified as clinical failures at day 28 to 32 (microbiologically evaluable intent-to-treat population)

Treatment group	Patient	Baseline pathogen	Pathogen recovered at follow-up	Comments
Azithromycin	I	S. pneumoniae	No growth
	J	H. influenzae	H. influenzae	Azithromycin MIC at baseline and follow-up, 1 and 2 μg/ml, respectively. Both isolates were β-lactamase positive
	K	S. pneumoniae	S. pneumoniae	Azithromycin MIC at baseline and follow-up, 0.12 and 8 μg/ml, respectively
	L	H. influenzae	M. catarrhalis
Amoxicillin-clavulanate	M	H. influenzae	No growth
	N	H. influenzae	H. influenzae	Amoxicillin MIC at both baseline and follow-up, 0.5 μg/ml. Both isolates were β-lactamase negative
	O	S. pneumoniae	H. influenzae